• 1. Exchanged ligands on the surface of a giant cluster: [(MoO3)176(H2O)63(CH3OH)17Hn](32 – n)–
  Chem. Commun., 1998, 1501-1502
• 2. Fast-Track to Research Data Management in Experimental Material Science-Setting the Ground for Research Group Level Materials Digitalization.
  LarsBanko,AlfredLudwig
• 3. Excimer and exciplex formation in a pair of bright phosphorescent isomers constructed from Cu3(pyrazolate)3 and Cu3I3 coordination luminophores?
  Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459
• 4. Emerging investigator series: kinetics of diopside reactivity for carbon mineralization in mafic–ultramafic rocks
  BrianaAguila,LandonHardee,H.ToddSchaef,SiavashZare,MohammadJavadAbdolhosseiniQomi,JarrodV.Crum,JadeE.HollimanJr.,ElenaTajueloRodriguez,LawrenceM.Anovitz,KevinM.Rosso,QuinR.S.Miller
• 5. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833

• Solvents and Organic Chemicals Organic Compounds Organic nitrogen compounds Organonitrogen compounds Amines Secondary amines

Introduction to N-(1,2-dimethylpropyl)cyclopropanamine Hydrochloride (CAS No. 1093403-67-8)

N-(1,2-dimethylpropyl)cyclopropanamine hydrochloride is a chemical compound that has garnered significant attention in the field of pharmaceutical research and development. This compound, with the CAS number 1093403-67-8, belongs to a class of molecules that exhibit intriguing pharmacological properties. The hydrochloride salt form of this compound enhances its solubility in aqueous solutions, making it more suitable for various biomedical applications.

The molecular structure of N-(1,2-dimethylpropyl)cyclopropanamine hydrochloride consists of a cyclopropane ring substituted with a 1,2-dimethylpropyl group and an amine functional group, which is further converted into its hydrochloride salt. This unique structural arrangement contributes to its distinct chemical and biological characteristics. The cyclopropane ring is known for its high reactivity and stability, while the amine group provides a site for further chemical modifications and interactions with biological targets.

In recent years, there has been growing interest in exploring the potential of cyclopropane derivatives as pharmacological agents. The compound N-(1,2-dimethylpropyl)cyclopropanamine hydrochloride has been studied for its potential role in modulating various biological pathways. Research indicates that this compound may interact with specific enzymes and receptors, leading to therapeutic effects. For instance, studies have suggested that it might have anti-inflammatory properties by inhibiting the activity of certain inflammatory mediators.

One of the most compelling aspects of N-(1,2-dimethylpropyl)cyclopropanamine hydrochloride is its ability to cross the blood-brain barrier, which is crucial for many central nervous system (CNS) drugs. This property makes it an attractive candidate for developing treatments for neurological disorders. Current research is focusing on understanding how this compound interacts with CNS receptors and whether it can be used to alleviate symptoms associated with conditions such as depression and anxiety.

The synthesis of N-(1,2-dimethylpropyl)cyclopropanamine hydrochloride involves multi-step organic reactions that require precise control over reaction conditions. The process typically begins with the formation of the cyclopropane ring followed by the introduction of the 1,2-dimethylpropyl group and the amine functional group. The final step involves converting the free amine into its hydrochloride salt to improve solubility and stability. Advanced synthetic techniques have been employed to optimize yield and purity, ensuring that the final product meets pharmaceutical standards.

Evaluation of the pharmacokinetic properties of N-(1,2-dimethylpropyl)cyclopropanamine hydrochloride has revealed interesting findings regarding its absorption, distribution, metabolism, and excretion (ADME). Studies have shown that this compound exhibits moderate oral bioavailability and a relatively long half-life, suggesting potential for once-daily dosing in therapeutic applications. Additionally, preliminary toxicology studies indicate that it is well-tolerated at moderate doses, although further research is needed to fully assess its safety profile.

The potential therapeutic applications of N-(1,2-dimethylpropyl)cyclopropanamine hydrochloride extend beyond CNS disorders. Research is ongoing to explore its efficacy in treating conditions such as pain syndromes and autoimmune diseases. The compound's ability to modulate inflammatory pathways makes it a promising candidate for developing novel anti-inflammatory agents. Moreover, its structural features may allow it to interact with other biological targets, opening up possibilities for treating a wide range of diseases.

In conclusion, N-(1,2-dimethylpropyl)cyclopropanamine hydrochloride (CAS No. 1093403-67-8) is a fascinating compound with significant potential in pharmaceutical applications. Its unique molecular structure and pharmacological properties make it an attractive candidate for further research and development. As our understanding of its mechanisms of action continues to grow, so too does the likelihood that it will play a crucial role in future medical treatments.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)